⌘K
Loading ticker…
As of 2026-08-25, Xtant Medical Holdings, Inc. (XTNT) has a 3-month relative strength percentile of 14 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 35. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 8.9%, relative volume 0.33×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
XTNT is in a stage 4 downtrend, week 3. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -21.6% / -41.6%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
XTNT is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $837K notional.
Held by 2 ETFs · $1M across latest filings · largest weight 0.00% (VXF).
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $837K | — |
| VXFVanguard Extended Market ETF | 0.00% | $288K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | XTNT Jan avg: 0.83% median: -5.50% win: 50% σ: 28.90% n: 4 2022-04-12 → 2026-07-31 | XTNT Feb avg: 6.74% median: 7.95% win: 50% σ: 20.80% n: 4 2022-04-12 → 2026-07-31 | XTNT Mar avg: -8.39% median: -4.99% win: 25% σ: 15.50% n: 4 2022-04-12 → 2026-07-31 | XTNT Apr avg: -5.51% median: -3.15% win: 20% σ: 11.45% n: 5 2022-04-12 → 2026-07-31 | XTNT May avg: -2.59% median: -11.37% win: 20% σ: 19.44% n: 5 2022-04-12 → 2026-07-31 | XTNT Jun avg: 6.26% median: -8.87% win: 40% σ: 26.55% n: 5 2022-04-12 → 2026-07-31 | XTNT Jul avg: -1.43% median: -0.43% win: 40% σ: 13.63% n: 5 2022-04-12 → 2026-07-31 | XTNT Aug avg: 10.96% median: 6.60% win: 100% σ: 13.33% n: 4 2022-04-12 → 2026-07-31 (current) | XTNT Sep avg: 6.08% median: -3.39% win: 50% σ: 22.94% n: 4 2022-04-12 → 2026-07-31 | XTNT Oct avg: 2.56% median: -3.06% win: 50% σ: 24.51% n: 4 2022-04-12 → 2026-07-31 | XTNT Nov avg: -14.05% median: -14.64% win: 25% σ: 18.71% n: 4 2022-04-12 → 2026-07-31 | XTNT Dec avg: 10.54% median: 9.11% win: 75% σ: 17.15% n: 4 2022-04-12 → 2026-07-31 |